Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel
Science Advances · 20.03.2026 · 12 (12)
DOI: 10.1126/sciadv.adz7615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.03.2026. Verfasst von Yiyi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Complex Severe and Rare Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union M…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Cisplatin, Nanogels, Platinum. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Beijing Nova Program, National key R&D program of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Cisplatin’s (Cis’s) antitumor efficacy is limited by dose-dependent toxicity due to nonspecific tissue distribution. While targeted Cis delivery and combination therapies boost therapeutic efficacy, developing multifunctional yet simplified formulations remains challenging. Inspired by the Cis’s interaction with DNA, here, we transformed Cis into a reversible photothermal agent through the platinum-phosphate (Pt-phos) interaction within a hyaluronan (HA) nanogel (named as HA/PtP) to afford synergistic photothermal therapy (PTT) and chemotherapy. The HA/PtP nanogel exhibits near infrared absorption and 32.08% photothermal conversion efficiency, and degrades to release Cis through the reversible Pt-phos interaction under acidic conditions. Leveraging HA’s intrinsic CD44 targeting, HA/PtP nanogel simultaneously enables highly efficient PTT and targeted chemotherapy in 4T1 breast tumor xenografts. Moreover, HA/PtP-based PTT successfully mimics hyperthermic intraperitoneal chemotherapy (HIPEC) but with alleviated Cis toxicity in MC38 metastatic mouse model. This HA/PtP nanogel represents a rationally designed Cis nanomedicine integrating the PTT with self-targeting and facile preparation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Complex Severe and Rare Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100005, P. R. China.
- State Key Laboratory of Molecular Oncology and Department of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union…
ORCID-Profile: Yiyi Zhang, Huimin Wang, Weiqi Zhang
Förderung
- Beijing Nova Program
- National key R&D program of China
- Beijing Natural Science Foundation
- the CAMS Innovation Fund for Medical Science
- Haihe Laboratory of Cell Ecosystem Innovation Fund
Zitieren
APA
Zhang, Y., Wang, H., Guo, H., Gou, X., Hao, X., Li, J., Deng, H., & Zhang, W. (2026). Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel. Science Advances, 12(12). https://doi.org/10.1126/sciadv.adz7615
Vancouver
Zhang Y, Wang H, Guo H, Gou X, Hao X, Li J, et al. Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel. Science Advances. 2026;12(12). doi:10.1126/sciadv.adz7615
BibTeX
@article{Zhang2026,
author = {Zhang, Yiyi and Wang, Huimin and Guo, Hua and Gou, Xiaorong and Hao, Xinxin and Li, Jiayi and Deng, Hong and Zhang, Weiqi},
title = {Transforming cisplatin into targeted photothermal chemotherapeutics through the platinum-phosphate coordination within a hyaluronan nanogel},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {12},
doi = {10.1126/sciadv.adz7615}
}
EUVIMED